Get started
Author

Fabrizio Nelli

Observed names: F Nelli, F. Nelli, FABRIZIO NELLI, Nelli Fabrizio, Nelli, Fabrizio
Observed institutions: Università degli Studi della Tuscia, Università Campus Bio-Medico, University of Campania "Luigi Vanvitelli", Azienda Ospedaliera San Giovanni Addolorata, Policlinico Umberto I, Azienda Ospedaliera San Camillo-Forlanini, Azienda Sanitaria Locale Viterbo, Azienda Ospedaliera S.Giuseppe Moscati, Ospedale di Belcolle, Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Carlo Forlanini Hospital, Ospedale San Pietro Fatebenefratelli, Hospital of Prato, Instituto Nazionale Tumori Regina Elena, University of Naples Federico II, Sapienza University of Rome
ORCID: 0000-0001-8374-1362
Observed ORCID: 0000-0001-8374-1362
OpenAlex ID: A5020421670
Epidemiology of Nephrolithiasis Today
2004 · M. Amato, M.L. Lusini, et al. · Urologia Internationalis · 121
Adjuvant chemotherapy in muscle‐invasive bladder carcinoma
2006 · Enzo Maria Ruggeri, Diana Giannarelli, et al. · Cancer · 81
PDF
Quality of life in lung cancer patients
2001 · C. Gridelli, F. Perrone, et al. · Annals of Oncology · 70
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials
2018 · Cesare Gridelli, Alessandro Morabito, et al. · Journal of Clinical Oncology · 69
Up‐front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases
2006 · Luca Moscetti, Fabrizio Nelli, et al. · Cancer · 67
Adjuvant Aromatase Inhibitor Therapy in Early Breast Cancer: What Factors Lead Patients to Discontinue Treatment?
2015 · Luca Moscetti, Maria Agnese Fabbri, et al. · Tumori Journal · 50
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma
2003 · Federico Cappuzzo, Giovanni Selvaggi, et al. · Cancer · 46
PDF
Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy‐proven Stage IIIA(N2) nonsmall cell lung carcinoma
2003 · Filippo De Marinis, Fabrizio Nelli, et al. · Cancer · 44
Single Colon Metastasis from Breast Cancer a Clinical Case Report
2005 · Carlo Signorelli, Donatella Pomponi-Formiconi, et al. · Tumori Journal · 41
A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer
2002 · M.Rita Migliorino, Filippo De Marinis, et al. · Lung Cancer · 25
Gemcitabine and Cisplatin in the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer: Impact of Comorbidities on Safety and Efficacy Outcome
2005 · L. Moscetti, F. Nelli, et al. · Journal of Chemotherapy · 18
Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study
2021 · F. Nelli, A. Fabbri, et al. · Annals of Oncology · 16
PDF
Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes
2012 · Fabrizio Nelli, Luca Moscetti, et al. · International Journal of Clinical Oncology · 16
Rhabdomyolysis from erlotinib: A case report
2011 · Luca Moscetti, Fabrizio Nelli, et al. · Tumori Journal · 14
Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer
2003 · Filippo De Marinis, Maria Rita Migliorino, et al. · Lung Cancer · 14
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first‐line treatment in patients with poor‐prognosis small cell lung carcinoma
2005 · Filippo De Marinis, Fabrizio Nelli, et al. · Cancer · 13
PDF
Weekly Vinorelbine and Docetaxel as Second-Line Chemotherapy for Pretreated Non-Small Cell Lung Cancer Patients: a Phase I-II Trial
2004 · F. Nelli, G. Naso, et al. · Journal of Chemotherapy · 13
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study
2013 · Luca Moscetti, Fabrizio Nelli, et al. · Investigational New Drugs · 12
Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade
2024 · Fabrizio Nelli, Agnese Fabbri, et al. · Cancers · 10
PDF
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients
2022 · Enzo Maria Ruggeri, Fabrizio Nelli, et al. · Scientific Reports · 10
PDF
Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis
2019 · CARLO SIGNORELLI, MARIO GIOVANNI CHILELLI, et al. · Anticancer Research · 10
PDF
Management of cutaneous adverse effects during treatment with ZD1839 in advanced non-small cell lung cancer (NSCLC): Surprising efficacy of early local treatment
2004 · E. Cortesi, A. De Pasquale Ceratti, et al. · Journal of Clinical Oncology · 10
Effects of Acetaminophen Exposure on Outcomes of Patients Receiving Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
2023 · Fabrizio Nelli, Antonella Virtuoso, et al. · Current Oncology · 9
PDF
Impact of previous corticosteroid exposure on outcomes of patients receiving immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective observational study
2022 · F. Nelli, A. Virtuoso, et al. · Cancer Chemotherapy and Pharmacology · 9
Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
2021 · F. Nelli, A. Fabbri, et al. · Annals of Oncology · 9
Works count: 90
Citation count: 941
H-index: 14
I10-index: 22
Year
Topic
Type